What should you know about embryo transfer to surrogate mother?

In a gestational-carrier arrangement, the embryo is created through assisted reproduction and transferred to the carrier’s uterus; the carrier may not provide the egg. The uterus is prepared with a treatment plan that can include hormone medicines and monitoring. The clinic coordinates embryo information, medical records, consent, and the timing of transfer. Laws and professional requirements differ by location, so eligibility and documentation must be checked locally before treatment begins.

The intended parents and carrier should receive separate counselling and independent legal advice where required. Confirm who manages medicines, appointments, emergency contact, and communication after transfer. The carrier should report new symptoms and attend every planned check. Follow the fertility team’s instructions rather than changing medication or activity independently. Background reading on [IVF](/treatments/fertility-and-assisted-reproduction/ivf/) and [Micronised Progesterone](/materials/micronised-progesterone/) may help explain the medical components.

The carrier should contact the clinic for heavy bleeding, worsening abdominal or pelvic pain, fever, faintness, breathing difficulty, or pronounced swelling. Severe pain or collapse needs urgent medical assessment. A symptom may have a harmless explanation, but the treating team needs to assess it in the context of medicines, ovarian treatment, and pregnancy monitoring.

Ask how the uterus will be prepared, which medicines continue after transfer, who receives test results, and how urgent concerns are handled. Clarify the consent process, local legal requirements, privacy arrangements, and the schedule for pregnancy testing and scans.